Alpine Associates Management’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Alpine Associates Management’s Portfolio ICVX Stock Details ICVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,456,700	Closed	-$23M	–	55
2023 Q4	$23M	Buy	+1,456,700	New	+$14M	1.18%	24

Alpine Associates Management's ICVX Position: Q1 2024 in Review

Alpine Associates Management sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 1,456,700 shares — an estimated $23M sold.

Alpine Associates Management first reported a position in ICVX in Q4 2023 and held it in 1 quarter. The position peaked at $23M in Q4 2023. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

Alpine Associates Management reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Alpine Associates Management sold 1,456,700 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $23M.
Alpine Associates Management first reported a position in Icosavax, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Alpine Associates Management's Icosavax, Inc. Common Stock position peaked at $23M in Q4 2023.
0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on Alpine Associates Management's 13F filing for Q1 2024, filed 9 May 2024.